Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia. The company designs and manufactures a suite of real-time polymerase chain reaction based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, the company offers MethylEasy for DNA bisulphite modification of histones for screening of cancer and embryonic development, as well as use in stem cell technologies. Genetic Signatures Limited was founded in 2001 and is headquartered in Sydney, Australia.